3h
CAR Magazine on MSNMG Cyberster (2025) review: driven on road and trackCAR drives the electric MG Cyberster► 496bhp, 3.2sec 0-62mph, butterfly doors► The first electric roadster – but is it a good one? MG has sold 86,500 EVs since its first went on sale in 2019, making ...
An all-new MG 4 electric hatch has debuted to replace the current three-year-old model amid slow sales in the competitive ...
A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.
The TKI zongertinib is currently being reviewed by the FDA for a potential approval for patients with HER2 mutation–positive ...
SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.
6d
Verywell Health on MSN10 Foods That Pack More Vitamin C Than an OrangeOranges are a citrus fruit known for their immune-boosting properties, due to their high vitamin C content. However, there ...
1d
Verywell Health on MSNCoffee or Matcha: Which Is Better for Energy and Wellness?Coffee and matcha are both known for their energy-boosting benefits. However, they also offer an array of health benefits.
Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) ...
FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.
Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.
Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results